Cephalosporins: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
* Class of β-lactam antibiotics |
|||
*First-generation |
|||
* Cephamycins ([[cefoxitin]] and relatives) are commonly included under second-generation cephalosporin |
|||
**[[Cefazolin]] |
|||
** Narrower spectrum but resistance to [[β-lactamases]] |
|||
**[[Cephalothin]] |
|||
* Organized into generations, with increasing generations having broader gram-negative coverage but losing some gram-positive coverage |
|||
**[[Cephapirin]] |
|||
* Third-generation are considered extended-spectrum; therefore, [[β-lactamases]] that hydrolyze third-generation cephalosporins are called [[extended-spectrum β-lactamases]] |
|||
**[[Cephradine]] |
|||
*Second-generation |
|||
{| class="wikitable" |
|||
**[[Cefamandole]] |
|||
!Generation |
|||
**[[Cefonicid]] |
|||
!Antibiotic |
|||
**[[Cefuroxime]] |
|||
!Route |
|||
*Third-generation |
|||
!Notes |
|||
**[[Cefoperazone]] |
|||
|- |
|||
**[[Cefotaxime]] |
|||
| rowspan="8" |First |
|||
**[[Ceftazidime]] |
|||
|[[cefadroxil]] |
|||
|PO |
|||
**[[Ceftriaxone]] |
|||
| |
|||
*Fourth-generation |
|||
|- |
|||
**[[Cefepime]] |
|||
|[[cefazolin]] |
|||
|IV |
|||
*Anti-MRSA |
|||
| |
|||
**[[Ceftaroline]] |
|||
|- |
|||
**[[Ceftobiprole]] |
|||
|[[cephacetrile]] |
|||
*Cephamycins |
|||
| |
|||
**[[Cefmetazole]] |
|||
| |
|||
**[[Cefotetan]] |
|||
|- |
|||
**[[Cefoxitin]] |
|||
|[[cephalexin]] |
|||
*Siderophore cephalosporin |
|||
|PO |
|||
**[[Cefiderocol]] |
|||
| |
|||
*Oral |
|||
|- |
|||
**[[Cefaclor]] |
|||
|[[cephaloridine]] |
|||
| |
|||
**[[Cefdinir]] |
|||
| |
|||
**[[Cefditoren]] |
|||
|- |
|||
**[[Cefetamet]] |
|||
|[[cephalothin]] |
|||
|IV |
|||
**[[Cefpodoxime]] |
|||
|previously used to predict cefazolin susceptibilty |
|||
**[[Cefprozil]] |
|||
|- |
|||
**[[Ceftibuten]] |
|||
|[[cephapirin]] |
|||
| |
|||
**[[Cephalexin]] |
|||
| |
|||
**[[Cephradine]] |
|||
|- |
|||
|[[cephradine]] |
|||
|PO/IV |
|||
| |
|||
|- |
|||
| rowspan="9" |Second |
|||
|[[cefaclor]] |
|||
|PO |
|||
| |
|||
|- |
|||
|[[cefamandole]] |
|||
| |
|||
| |
|||
|- |
|||
|[[cefonicid]] |
|||
| |
|||
| |
|||
|- |
|||
|[[ceforanide]] |
|||
| |
|||
| |
|||
|- |
|||
|[[cefotiam]] |
|||
|PO/IV |
|||
| |
|||
|- |
|||
|[[cefprozil]] |
|||
|PO |
|||
|sometimes thought of as a third-generation |
|||
|- |
|||
|[[cefuroxime]] |
|||
|PO/IV |
|||
| |
|||
|- |
|||
|[[cefuzonam]] |
|||
| |
|||
|severe skin reactions |
|||
|- |
|||
|[[loracarbef]] |
|||
|PO |
|||
| |
|||
|- |
|||
| rowspan="4" |[[Cephamycins]] |
|||
|[[cefmetazole]] |
|||
| |
|||
| |
|||
|- |
|||
|[[cefotetan]] |
|||
| |
|||
| |
|||
|- |
|||
|[[cefoxitin]] |
|||
| |
|||
| |
|||
|- |
|||
|[[flomoxef]] |
|||
| |
|||
| |
|||
|- |
|||
| rowspan="12" |Third |
|||
|[[cefdinir]] |
|||
|PO |
|||
| |
|||
|- |
|||
|[[cefditoren]] |
|||
|PO |
|||
| |
|||
|- |
|||
|[[cefixime]] |
|||
|PO |
|||
| |
|||
|- |
|||
|[[cefoperazone]] |
|||
|IV |
|||
|[[Cefoperazone-sulbactam|coformulated with sulbactam]] |
|||
|- |
|||
|[[cefotaxime]] |
|||
|IV |
|||
|very similar to [[ceftriaxone]] |
|||
|- |
|||
|[[cefpiramide]] |
|||
| |
|||
|sometimes described as a fourth-generation; may be active against [[Pseudomonas aeruginosa]] |
|||
|- |
|||
|[[cefpodoxime]] |
|||
|PO |
|||
| |
|||
|- |
|||
|[[cefsulodin]] |
|||
|PO |
|||
|sometimes described as a fourth-generation; may be active against [[Pseudomonas aeruginosa]] |
|||
|- |
|||
|[[ceftazidime]] |
|||
|IV |
|||
|active against [[Pseudomonas aeruginosa]]; may be [[Ceftazidime-avibactam|coformulated with avibactam]] |
|||
|- |
|||
|[[ceftibuten]] |
|||
|PO |
|||
| |
|||
|- |
|||
|[[ceftizoxime]] |
|||
| |
|||
| |
|||
|- |
|||
|[[ceftriaxone]] |
|||
|IV |
|||
| |
|||
|- |
|||
| rowspan="2" |Fourth |
|||
|[[cefepime]] |
|||
|IV |
|||
|active against [[Pseudomonas aeruginosa]] and [[AmpC β-lactamase|AmpC producers]] |
|||
|- |
|||
|[[cefpirome]] |
|||
| |
|||
| |
|||
|- |
|||
| rowspan="3" |Fifth |
|||
|[[ceftaroline]] |
|||
|IV |
|||
|active against MRSA; may be coformulated with [[Ceftazidime-avibactam|avibactam]] |
|||
|- |
|||
|[[ceftobiprole]] |
|||
|IV |
|||
|active against MRSA |
|||
|- |
|||
|[[ceftolozane]] |
|||
|IV |
|||
|[[Ceftolozane-tazobactam|coformulated with tazobactam]]; active against [[Pseudomonas aeruginosa]] and [[Extended-spectrum β-lactamases|ESBL producers]] |
|||
|- |
|||
|Siderophore |
|||
|[[cefiderocol]] |
|||
|IV |
|||
|} |
|||
== Further Reading == |
== Further Reading == |
Latest revision as of 11:12, 4 September 2022
- Class of β-lactam antibiotics
- Cephamycins (cefoxitin and relatives) are commonly included under second-generation cephalosporin
- Narrower spectrum but resistance to β-lactamases
- Organized into generations, with increasing generations having broader gram-negative coverage but losing some gram-positive coverage
- Third-generation are considered extended-spectrum; therefore, β-lactamases that hydrolyze third-generation cephalosporins are called extended-spectrum β-lactamases
Further Reading
- Comparison of various cephalosporins at Antimicrobe. http://www.antimicrobe.org/d19tab1.htm